Latest Breaking News On - Andy thacker zoe alexander - Page 4 : comparemela.com

Press release content from Globe Newswire. The AP news staff was not involved in its creation. DeepVerge PLC: Microtox® BT Evaluation of SARS-CoV-2 from breath test with Clinical Samples Deepverge PLCMarch 17, 2021 GMT YORK, United Kingdom, March 17, 2021 (GLOBE NEWSWIRE) DeepVerge (LSE:DVRG.L), the environmental and life science AI company, announces initial data for ongoing Phase III clinical studies on the detection of SARS-CoV-2 on breath samples and identification of confirmed COVID19 positive patients . Since Q3 2020, DeepVerge scientists have been working under laboratory conditions with the Spike Protein (“S-Protein”) of SARS-CoV-2 on the SARS-CoV-2 virus inside the Containment Level 3 (“CL3″) laboratories at the University of Aberdeen.  In these studies, they have detected and identified the virus S-Protein in quantities at 40 femtogram[i] per millilitre (“Fg/mL”) at close to 100% sensitivity and specificity on DeepVerge’s Microtox® BT[ii] nano

United kingdomDeepverge microtoxGerard brandonNeil baldwin andrewAndy thacker zoe alexanderOptimers aptamer groupAvacta groupUniversity of aberdeenAdvisory partners limited nominated adviserRoyal college of surgeonsSpike proteinContainment levelRoyal collegeUnited kingdom target product profileRapid breath testPartners limited